Parkinson's disease, adaptive deep brain stimulation and FDA

US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
FDA approves first adaptive deep brain stimulation system for Parkinson’s disease
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the manufacturer.
FDA OKs First Adaptive DBS System for Parkinson’s Disease
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized neuromodulation that responds to the patient’s changing needs.
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation ap | The company said its U.
Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no
FDA OKs adaptive brain pacemaker for Parkinson's treatment
The Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease symptoms of Parkinson's disease, which affects nearly 1 million people in the United States.
In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced stimulation deep in the brain.
FDA approves Medtronic’s adaptive technology for Parkinson’s
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
Studies of Parkinson's disease have long overlooked Pacific populations—meta-analysis shows why that must change
A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...
Rock legend battling Parkinson’s wants to ‘say a proper goodbye’ to fans
“He’s very happy to be coming back and very emotional about this,” she said. “Parkinson’s is a progressive disease. It’s not ...
Jake Paul causes Mike Tyson Parkinson’s disease stir in wild interview after controversial fight
The Tyson-Paul fight had to be re-scheduled from July 20 to Nov. 15 after Tyson had a medical emergency on a plane during the ...
Why Is Parkinson's Disease Twice As Common in Men?
A new study reveals that T cells mistakenly attack brain cells expressing PINK1, contributing to Parkinson’s disease. The ...
News Medical on MSN7d
Cholesterol metabolite linked to Parkinson's disease development in mice
Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...
emjreviews.com3h
Teleneurorehabilitation: A Safe, Effective Alternative for Parkinson’s Treatment
Telemedicine helps Parkinson’s patients—safe, effective rehab via video calls. Discover the TELEPARK trial’s promising results.
Mike Tyson Sets Record Straight On Parkinson’s Disease Rumors
Mike Tyson is setting the record straight amid rumors he has Parkinson's Disease following comments made by Jake Paul.   The ...
Hosted on MSN1d
FDA Approves Adaptive Deep Brain Stimulator for Parkinson's Disease
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
Jerry Butler, Legendary Soul Singer, Dies at 85 Following Parkinson's Disease Diagnosis
Jerry Butler has died at the age of 85. Butler was the original lead singer of the Impressions before embarking on a ...